India Pharma Outlook Team | Tuesday, 16 September 2025
A key equity stake in its subsidiary and a major investment in a new state-of-the-art oncology facility have been announced by Apollo Hospitals Enterprise Ltd (AHEL) as a significant strategic move.
The company's ambitious expansion and growing dedication to providing specialist healthcare services throughout India are indicated by the decisions, which were accepted at a recent board meeting. It is anticipated that these two actions will strengthen AHEL's position as the market leader and its chances for future growth.
The International Finance Corporation's (IFC) 31% equity holding in Apollo Health and Lifestyle Limited has been approved by the board. The total value of the deal is Rs. 12,540.68 million. By combining ownership of its subsidiary, AHEL streamlines operations and guarantees alignment with its overarching business plan. The Competition Commission of India has not yet approved the deal.
Also Read: Schneider Electric, Apollo Hospitals Boost Energy Reliability
An essential part of the Apollo ecosystem is Apollo Health and Lifestyle Limited. Through its network of specialty hospitals, clinics, diagnostic centers, and dental and dialysis facilities, the corporation plays a significant role in offering a broad range of health services. With a reported turnover of Rs. 15,535 million for the fiscal year that concluded on March 31, 2025, AHLL demonstrated its substantial revenue contribution to the parent firm.
Separately, but no less significant, the board of AHEL has approved the construction of a new, all-inclusive oncology facility in Gurugram. An impressive Rs. 5,730 million has been invested in this project. A state-of-the-art Proton Beam Therapy System, a highly sophisticated cancer treatment method renowned for its accuracy in locating tumors while reducing harm to nearby healthy tissue, is expected to be installed in the new facility.
